BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intarcia Therapeutics, Inc. 

155 Seaport Boulevard
11th Floor
Boston  Massachusetts  02210  U.S.A.
Phone: 617-936-2500 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



 Key Statistics


Email:
Ownership: Private

Web Site: Intarcia
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Intarcia Names Emad Rizk, MD, To Board Of Directors 5/19/2015 11:01:12 AM
Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named 5/18/2015 10:53:00 AM
Intarcia Appoints James P. Brady Vice President, Human Resources 5/4/2015 9:24:42 AM
Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead Itca 650 Launch In U.S. 5/4/2015 9:23:50 AM
Boston Startup Intarcia Nabs $225 Million in New Financing, Looks to Double Employment 4/28/2015 5:58:29 AM
Intarcia Therapeutics, Inc. And Numab AG Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications 3/20/2015 6:42:57 AM
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device 11/12/2014 6:12:53 AM
Boston's Intarcia Therapeutics, Inc. Touts Trial Results Of Potentially Revolutionary Type 2 Diabetes Treatment 10/2/2014 6:39:08 AM
Intarcia Therapeutics, Inc. Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 9/17/2014 8:58:43 AM
Intarcia Therapeutics, Inc. Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 9/12/2014 9:00:59 AM
123456